» Articles » PMID: 12072493

Characterization of Low- and Very-low-density Hepatitis C Virus RNA-containing Particles

Overview
Journal J Virol
Date 2002 Jun 20
PMID 12072493
Citations 271
Authors
Affiliations
Soon will be listed here.
Abstract

The presence of hepatitis C virus (HCV) RNA-containing particles in the low-density fractions of plasma has been associated with high infectivity. However, the nature of circulating HCV particles and their association with immunoglobulins or lipoproteins as well as the characterization of cell entry have all been subject to conflicting reports. For a better analysis of HCV RNA-containing particles, we quantified HCV RNA in the low-density fractions of plasma corresponding to the very-low-density lipoprotein (VLDL), intermediate-density lipoprotein, and low-density lipoprotein (LDL) fractions from untreated chronically HCV-infected patients. HCV RNA was always found in at least one of these fractions and represented 8 to 95% of the total plasma HCV RNA. Surprisingly, immunoglobulins G and M were also found in the low-density fractions and could be used to purify the HCV RNA-containing particles (lipo-viro-particles [LVP]). Purified LVP were rich in triglycerides; contained at least apolipoprotein B, HCV RNA, and core protein; and appeared as large spherical particles with a diameter of more than 100 nm and with internal structures. Delipidation of these particles resulted in capsid-like structures recognized by anti-HCV core protein antibody. Purified LVP efficiently bind and enter hepatocyte cell lines, while serum or whole-density fractions do not. Binding of these particles was competed out by VLDL and LDL from noninfected donors and was blocked by anti-apolipoprotein B and E antibodies, whereas upregulation of the LDL receptor increased their internalization. These results suggest that the infectivity of LVP is mediated by endogenous proteins rather than by viral components providing a mechanism of escape from the humoral immune response.

Citing Articles

Functional Role of Hepatitis C Virus NS5A in the Regulation of Autophagy.

Ke P, Yeh C Pathogens. 2024; 13(11).

PMID: 39599533 PMC: 11597459. DOI: 10.3390/pathogens13110980.


Hepatitis B virus entry, assembly, and egress.

Chuang Y, Ou J Microbiol Mol Biol Rev. 2024; 88(4):e0001424.

PMID: 39440957 PMC: 11653734. DOI: 10.1128/mmbr.00014-24.


Circulating microRNAs as potential biomarkers of physical activity in geriatric patients with HCV.

Al-Rawaf H, Gabr S, Iqbal A, Alghadir A BMC Mol Cell Biol. 2024; 25(1):18.

PMID: 39030480 PMC: 11264506. DOI: 10.1186/s12860-024-00514-8.


Inflammatory and Immune Mechanisms for Atherosclerotic Cardiovascular Disease in HIV.

Hmiel L, Zhang S, Obare L, Santana M, Wanjalla C, Titanji B Int J Mol Sci. 2024; 25(13).

PMID: 39000373 PMC: 11242562. DOI: 10.3390/ijms25137266.


Hepatitis C Virus E1E2 Structure, Diversity, and Implications for Vaccine Development.

Pierce B, Felbinger N, Metcalf M, Toth E, Ofek G, Fuerst T Viruses. 2024; 16(5).

PMID: 38793684 PMC: 11125608. DOI: 10.3390/v16050803.


References
1.
Miyamoto H, Okamoto H, Sato K, Tanaka T, Mishiro S . Extraordinarily low density of hepatitis C virus estimated by sucrose density gradient centrifugation and the polymerase chain reaction. J Gen Virol. 1992; 73 ( Pt 3):715-8. DOI: 10.1099/0022-1317-73-3-715. View

2.
Ishida S, Kaito M, Kohara M, Fujita N, Ikoma J, Adachi Y . Hepatitis C virus core particle detected by immunoelectron microscopy and optical rotation technique. Hepatol Res. 2001; 20(3):335-347. DOI: 10.1016/s1386-6346(01)00080-8. View

3.
Carrick R, Schlauder G, Peterson D, MUSHAHWAR I . Examination of the buoyant density of hepatitis C virus by the polymerase chain reaction. J Virol Methods. 1992; 39(3):279-89. DOI: 10.1016/0166-0934(92)90101-i. View

4.
THOMSSEN R, Bonk S, Thiele A . Density heterogeneities of hepatitis C virus in human sera due to the binding of beta-lipoproteins and immunoglobulins. Med Microbiol Immunol. 1993; 182(6):329-34. DOI: 10.1007/BF00191948. View

5.
Farci P, Shimoda A, Wong D, Cabezon T, De Gioannis D, Strazzera A . Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. Proc Natl Acad Sci U S A. 1996; 93(26):15394-9. PMC: 26415. DOI: 10.1073/pnas.93.26.15394. View